Comparative efficacy and safety of antipseudomonal β-lactams for pediatric febrile neutropenia-Reference-Cited by-同舟云学术

Comparative efficacy and safety of antipseudomonal β-lactams for pediatric febrile neutropenia

Published:2021-12-17 Issue:50 Volume:100 Page:e27266
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Tan Xinmei,Li Yan,Xi Jiaxi,Guo Sitong,Su Henghai,Chen Xiaoyu,Liang Xueyan

Funder

Natural Science Foundation of Guangxi Province

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference51 articles.

1. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia;Bodey;Ann Intern Med,1966

2. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America;Freifeld;Clin Infect Dis,2011

3. Evidence-based recommendations for antimicrobial use in febrile neutropenia in Japan: executive summary;Masaoka;Clin Infect Dis,2004

4. Comparison of antipseudomonal β-lactams for febrile neutropenia empiric therapy: systematic review and network meta-analysis;Horita;Clin Microbiol Infect,2017

5. Anti-pseudomonal β-lactams for the initial, empirical, treatment of febrile neutropenia: comparison of β-lactams;Paul;Cochrane Database Syst Rev,2010

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ÇOCUK HEMATOLOJİ/ONKOLOJİ HASTALARINDA PSEUDOMONAS SPP. KAN DOLAŞIM ENFEKSİYONLARININ ÖZELLİKLERİNİN DEĞERLENDİRİLMESİ;ANKEM Dergisi;2023-08-31

2. Optimal Dose of Cefoperazone-Sulbactam for Acute Bacterial Infection in Patients with Chronic Kidney Disease;Antibiotics;2022-04-30